TCL Archive NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness July 24, 1992
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application September 24, 1999